EIG
BMY icon

Ellenbecker Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Ellenbecker Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,843
Closed -$245K – 99
2023
Q2 		$245K Buy
3,843
+19
+0.5% +$1.27K 0.06% 82
2023
Q1 		$265K Buy
3,824
+17
+0.4% +$1.2K 0.07% 79
2022
Q4 		$273K Buy
3,807
+16
+0.4% +$1.21K 0.08% 74
2022
Q3 		$269K Buy
3,791
+16
+0.4% +$1.16K 0.09% 66
2022
Q2 		$290K Buy
3,775
+16
+0.4% +$1.22K 0.09% 66
2022
Q1 		$274K Buy
3,759
+18
+0.5% +$1.21K 0.08% 73
2021
Q4 		$233K Sell
3,741
-146
-4% -$8.56K 0.06% 78
2021
Q3 		$230K Sell
3,887
-41
-1% -$2.7K 0.07% 67
2021
Q2 		$262K Buy
3,928
+67
+2% +$4.37K 0.09% 59
2021
Q1 		$244K Sell
3,861
-38
-1% -$2.36K 0.09% 61
2020
Q4 		$242K Buy
+3,899
New +$240K 0.09% 58

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ellenbecker Investment Group's BMY Position: Q3 2023 in Review

Ellenbecker Investment Group sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,843 shares — an estimated $245K sold.

Ellenbecker Investment Group first reported a position in BMY in Q4 2020 and held it in 11 quarters. The position peaked at $290K in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Ellenbecker Investment Group reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Ellenbecker Investment Group sold 3,843 Bristol-Myers Squibb shares in Q3 2023, an estimated $245K.
  • Ellenbecker Investment Group first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 11 quarters.
  • Ellenbecker Investment Group's Bristol-Myers Squibb position peaked at $290K in Q2 2022.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Ellenbecker Investment Group's 13F filing for Q3 2023, filed 17 Oct 2023.